Creative Planning
NAVB

Creative Planning’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Creative Planning’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,805
Closed -$16K – 2177
2019
Q1 		$16K Hold
5,805
– – ﹤0.01% 1855
2018
Q4 		$12K Hold
5,805
– – ﹤0.01% 1823
2018
Q3 		$27K Hold
5,805
– – ﹤0.01% 1929
2018
Q2 		$27K Hold
5,805
– – ﹤0.01% 1893
2018
Q1 		$42K Hold
5,805
– – ﹤0.01% 1834
2017
Q4 		$42K Hold
5,805
– – ﹤0.01% 1812
2017
Q3 		$48K Hold
5,805
– – ﹤0.01% 1779
2017
Q2 		$59K Hold
5,805
– – ﹤0.01% 2399
2017
Q1 		$67K Sell
5,805
-50
-0.9% -$568 ﹤0.01% 2259
2016
Q4 		$75K Sell
5,855
-515
-8% -$8.17K ﹤0.01% 2061
2016
Q3 		$117K Buy
6,370
+50
+0.8% +$633 ﹤0.01% 1747
2016
Q2 		$67K Buy
6,320
+5
+0.1% +$98 ﹤0.01% 1943
2016
Q1 		$119K Hold
6,315
– – ﹤0.01% 1524
2015
Q4 		$168K Hold
6,315
– – ﹤0.01% 1313
2015
Q3 		$288K Hold
6,315
– – ﹤0.01% 996
2015
Q2 		$203K Buy
6,315
+1,065
+20% +$30.9K ﹤0.01% 869
2015
Q1 		$167K Hold
5,250
– – ﹤0.01% 1287
2014
Q4 		$198K Hold
5,250
– – ﹤0.01% 1147
2014
Q3 		$139K Hold
5,250
– – ﹤0.01% 1269
2014
Q2 		$155K Hold
5,250
– – ﹤0.01% 1174
2014
Q1 		$194K Hold
5,250
– – ﹤0.01% 1017
2013
Q4 		$217K Buy
5,250
+150
+3% +$5.87K ﹤0.01% 831
2013
Q3 		$270K Buy
5,100
+1,485
+41% +$86.6K 0.01% 653
2013
Q2 		$193K Buy
+3,615
New +$181K ﹤0.01% 696

Other funds holding NAVB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Creative Planning's NAVB Position: Q2 2019 in Review

Creative Planning sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2019, closing a stake of 5,805 shares — an estimated $16K sold.

Creative Planning first reported a position in NAVB in Q2 2013 and held it in 24 quarters. The position peaked at $288K in Q3 2015. 27 funds tracked by Wall St. Rank hold NAVB as of Q2 2019.

  • Creative Planning reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Creative Planning sold 5,805 Navidea Biopharmaceuticals Inc. shares in Q2 2019, an estimated $16K.
  • Creative Planning first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 24 quarters.
  • Creative Planning's Navidea Biopharmaceuticals Inc. position peaked at $288K in Q3 2015.
  • 27 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2019.

Based on Creative Planning's 13F filing for Q2 2019, filed 26 Jul 2019.